| Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin (NCT00770302) | AstraZeneca | 2008-10-01 |
| A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects (NCT00783484) | Pfizer | 2008-10-01 |
| Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects (NCT00759837) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer (NCT00749437) | University of Medicine and Dentistry of New Jersey | 2008-10-01 |
| The Effects of Passive and Active Vibration Therapy on Grip Strength and Myoelectric Activity (NCT00779610) | Logan College of Chiropractic | 2008-10-01 |
| Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents (NCT00790816) | Novartis Pharmaceuticals | 2008-10-01 |
| ORAL T-6: Oral Androgens in Man-6 (NCT00663793) | University of Washington | 2008-10-01 |
| Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder (NCT00694798) | Cadila Pharnmaceuticals | 2008-10-01 |
| Peripheral Metabolic Effects of Ghrelin (NCT00771940) | University of Aarhus | 2008-10-01 |
| Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) (NCT00705016) | Merck KGaA, Darmstadt, Germany | 2008-10-01 |
| Interleukin-2 Treatment for Wiskott-Aldrich Syndrome (NCT00774358) | Soma Jyonouchi | 2008-10-01 |
| A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) (NCT00799578) | Joel Lavine | 2008-10-01 |
| Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects (NCT02092168) | Bial - Portela C S.A. | 2008-10-01 |
| Influence of Physical Exercise on Endothelial Function in Pregnant Women (NCT00741312) | Universidad del Valle, Colombia | 2008-10-01 |
| Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection (NCT00823862) | Dynavax Technologies Corporation | 2008-10-01 |
| Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma (NCT00821080) | Massachusetts General Hospital | 2008-10-01 |
| To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Metformin (NCT00774553) | AstraZeneca | 2008-10-01 |
| Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer (NCT01414283) | Progenics Pharmaceuticals, Inc. | 2008-10-01 |
| Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma (NCT01213732) | Philogen S.p.A. | 2008-10-01 |
| Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease (NCT00766363) | FORUM Pharmaceuticals Inc | 2008-10-01 |
| Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers (NCT00777361) | AstraZeneca | 2008-10-01 |
| Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer (NCT00755885) | Cancer Research UK | 2008-10-01 |
| Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery (NCT00471471) | Ahmad Tarhini | 2008-10-01 |
| GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage (NCT01298830) | CellMed AG, a subsidiary of BTG plc. | 2008-10-01 |
| Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors (NCT00804336) | Dana-Farber Cancer Institute | 2008-10-01 |
| Contact Sensitization Potential of 828 Ointment (NCT00767676) | Healthpoint | 2008-10-01 |
| Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment (NCT00909831) | Abramson Cancer Center at Penn Medicine | 2008-10-01 |
| Safety and PK of Nikkomycin Z in Healthy Subjects (NCT00834184) | University of Arizona | 2008-10-01 |
| Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine (NCT01496950) | Hospital Israelita Albert Einstein | 2008-10-01 |
| Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment (NCT01280916) | University of Washington | 2008-10-01 |
| To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo (NCT00761540) | Novo Nordisk A/S | 2008-10-01 |
| A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) (NCT00874328) | National Cancer Center, Korea | 2008-10-01 |
| Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer (NCT00714246) | Milton S. Hershey Medical Center | 2008-10-01 |
| Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects (NCT00828581) | Eisai Inc. | 2008-10-01 |
| A Safety and Pharmacokinetic Study of CVX-096 in Type 2 Diabetics (NCT00886821) | Pfizer | 2008-10-01 |
| BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis (NCT00771329) | Biogen | 2008-10-01 |
| Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal (NCT00905333) | AstraZeneca | 2008-10-01 |
| Efficacy and Safety of an H.Pylori Vaccine in H.Pylori-Negative Adults (NCT00736476) | Novartis Vaccines | 2008-10-01 |
| Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers (NCT00806806) | Pacira Pharmaceuticals, Inc | 2008-10-01 |
| The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep (NCT00893269) | Johns Hopkins University | 2008-10-01 |
| Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males (NCT00722202) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| Shaolin Dan Tian Breathing Fosters Relaxed and Attentive Mind (NCT00988702) | The Hong Kong Polytechnic University | 2008-10-01 |
| A Study of Absorption, Metabolism, Excretion and Mass Balance After a Single Dose Administration of MK-0941 (MK-0941-016)(COMPLETED) (NCT00912002) | Merck Sharp & Dohme LLC | 2008-10-01 |
| Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00732745) | Case Comprehensive Cancer Center | 2008-10-01 |
| A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer (NCT00816764) | Astellas Pharma Inc | 2008-10-01 |
| An Explorative Study on the Pharmacokinetics and Pharmacodynamics of Sunitinib in Healthy Volunteers (NCT00904657) | University of Cologne | 2008-10-01 |
| A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer (NCT00779311) | Accelerated Community Oncology Research Network | 2008-10-01 |
| Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered (NCT00745576) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL (NCT00738829) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2008-10-01 |
| Iontophoretic Application of Terbinafine Gel to the Large Toe Nail (NCT00768768) | Transport Pharmaceuticals | 2008-10-01 |
| A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery (NCT01033994) | Merck KGaA, Darmstadt, Germany | 2008-10-01 |
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients (NCT01010880) | Biokine Therapeutics Ltd | 2008-10-01 |
| Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients (NCT00895466) | Pepscan Therapeutics | 2008-10-01 |
| Study of beta2-Microglobulin Removal by Standard Versus New High Cut-Off Haemodialysis Membrane (NCT00824837) | Austin Health | 2008-10-01 |
| Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia (NCT00771719) | Basilea Pharmaceutica | 2008-10-01 |
| Primary Care Patients With Depression for Internet-Based Social Support (NCT00886730) | University of Chicago | 2008-10-01 |
| Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors (NCT00776867) | Memorial Sloan Kettering Cancer Center | 2008-10-01 |
| A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid Tumors (NCT00786669) | Children's Hospital Medical Center, Cincinnati | 2008-10-01 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children (NCT00767416) | MedImmune LLC | 2008-10-01 |
| Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) (NCT00725283) | GlaxoSmithKline | 2008-10-01 |
| A Phase 1 Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration (NCT00782093) | Ophthotech Corporation | 2008-10-01 |
| Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016 (NCT00740649) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-10-01 |
| A Bioequivalence Study of Two Different Dosages of Isoniazid Tablet Formulations in Human Healthy Volunteers (NCT02043314) | Oswaldo Cruz Foundation | 2008-10-01 |
| Assess Safety, Tolerability and PK of AZD3199 in Japanese (NCT00772759) | AstraZeneca | 2008-10-01 |
| Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making (NCT00829478) | VA Connecticut Healthcare System | 2008-10-01 |
| A Thorough EKG Safety Study of TA-1790 (Avanafil) (NCT00769041) | VIVUS LLC | 2008-10-01 |
| Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III (NCT00846274) | SK Chemicals Co., Ltd. | 2008-10-01 |
| A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour (NCT00778128) | Clavis Pharma | 2008-10-01 |
| Effectiveness of Antiretroviral Therapy During Acute HIV Infection (NCT00705926) | Massachusetts General Hospital | 2008-10-01 |
| A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma (NCT00788060) | Daniel George, MD | 2008-10-01 |
| To Evaluate The Effect Of Ketoconazole, Ritonavir and Erythromycin on the Safety and Pharmacokinetics of Avanafil (NCT00770042) | VIVUS LLC | 2008-10-01 |
| A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis (NCT00771420) | MedImmune Ltd | 2008-10-01 |
| Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer (NCT00778167) | National Cancer Institute (NCI) | 2008-10-01 |
| Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer (NCT00782587) | Halozyme Therapeutics | 2008-10-01 |
| TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State. (NCT00744770) | Tibotec Pharmaceuticals, Ireland | 2008-10-01 |
| Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease (NCT00819949) | US Department of Veterans Affairs | 2008-10-01 |
| Relative Bioavailability of BI 44847 in Different Ethnic Groups and Evaluation of Effect of Diet and Acarbose Coadministration on Bioavailability Following Oral Administration of 200 mg BI 44847 in Healthy Male Volunteers (NCT02211950) | Boehringer Ingelheim | 2008-10-01 |
| Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females (NCT00787618) | Repros Therapeutics Inc. | 2008-10-01 |
| A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013) (NCT00759785) | Merck Sharp & Dohme LLC | 2008-09-30 |
| 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma (NCT00775268) | National Cancer Institute (NCI) | 2008-09-29 |
| EtOH Interaction Study (NCT00887367) | GlaxoSmithKline | 2008-09-29 |
| Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00729118) | Ohio State University Comprehensive Cancer Center | 2008-09-26 |
| A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 (NCT00721812) | GlaxoSmithKline | 2008-09-25 |
| A Study of GW685698X in Healthy Japanese Male Subjects (NCT00972673) | GlaxoSmithKline | 2008-09-24 |
| Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors (NCT00732420) | GlaxoSmithKline | 2008-09-24 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. (NCT00733551) | GlaxoSmithKline | 2008-09-23 |
| Phase I Study of GSK233705 in Healthy Japanese Male Subjects (NCT00964405) | GlaxoSmithKline | 2008-09-20 |
| Phase I Study of GW642444M in Healthy Japanese Male Subjects (NCT00964249) | GlaxoSmithKline | 2008-09-20 |
| Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia (NCT00742144) | GlaxoSmithKline | 2008-09-19 |
| Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic (NCT01424384) | GlaxoSmithKline | 2008-09-19 |
| Evaluation of Pneumococcal Vaccine Formulations in Elderly (NCT00756067) | GlaxoSmithKline | 2008-09-19 |
| Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis (NCT00757042) | Amgen | 2008-09-18 |
| Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset Schizophrenia (NCT00757497) | National Institute of Mental Health (NIMH) | 2008-09-17 |
| Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets (NCT01217190) | MonoSol Rx | 2008-09-16 |
| Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer (NCT00707707) | AstraZeneca | 2008-09-15 |
| Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival (NCT00742001) | Terumo BCTbio | 2008-09-10 |
| Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer (NCT00924313) | National Cancer Institute (NCI) | 2008-09-10 |
| Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours (NCT00750841) | AstraZeneca | 2008-09-09 |
| Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC (NCT00746733) | Shire | 2008-09-08 |
| A Study of LY2228820 in Participants With Advanced Cancer (NCT01393990) | Eli Lilly and Company | 2008-09-04 |